Topiramate in the treatment of chronic migraine

被引：0
|
作者：
Azimova, Yu E. [1 ]
Tabeeva, G. R. [1 ]
机构：
[1] Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2012年 / 112卷 / 12期
关键词：
migraine; prevention; topiramate; CHRONIC DAILY HEADACHE; LOW-DOSE TOPIRAMATE; DOUBLE-BLIND; CONTROLLED-TRIAL; PREVENTIVE THERAPY; EPISODIC MIGRAINE; ANTICONVULSANTS; PROPHYLAXIS; MULTICENTER; EFFICACY;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Patients with frequent episodic and chronic migraine, which is often complicated with drug abuse, are resistant to treatment. An objective of the study was to evaluate the efficacy and safety of topalepsin (topiramate) in the preventive treatment of migraine. Thirty patients with frequent episodic and chronic migraine were treated with topalepsin (100 mg daily) during 6 months. After treatment, there was a significant reduction in the number of days with headache and migraine attacks as well as their duration, severity of concomitant symptoms and amount of analgesics used by patients.
引用
收藏
页码：31 / 35
页数：5
相关论文
共 50 条
  • [41] Topiramate in the preventive treatment of migraine: experience in a tertiary center
    Krymchantowski, AV
    Tavares, C
    Penteado, JD
    Adriano, M
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2004, 62 (01) : 91 - 95
  • [42] Predictors of a negative response to topiramate therapy in patients with chronic migraine
    Rothrock, JF
    Parada, VA
    Drinkard, R
    Zweifler, RM
    Key, KE
    HEADACHE, 2005, 45 (07): : 932 - 935
  • [43] New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
    Edvinsson, Lars
    Linde, Mattias
    LANCET, 2010, 376 (9741): : 645 - 655
  • [44] Efficacy and tolerability of topiramate in the prophylactic treatment of pediatric migraine
    Cruz, M.
    Valencia, I
    Legido, A.
    Kothare, S., V
    Khurana, D.
    Huntley, H.
    Melvin, J. J.
    Marks, H.
    ANNALS OF NEUROLOGY, 2006, 60 : S153 - S154
  • [45] Evaluating the efficacy, safety, and tolerability of topiramate for the prevention of chronic migraine
    Diener, H. C.
    Goadsby, P. J.
    Bussone, G.
    van Oene, J.
    Lahaye, M.
    Schwalen, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 22 - 22
  • [46] Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
    Lai, K. -L.
    Niddam, D. M.
    Fuh, J. -L.
    Chen, S. -P.
    Wang, Y. -F.
    Chen, W. -T.
    Wu, J. -C.
    Wang, S. -J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 135 (04): : 476 - 483
  • [47] Pain catastrophizing as predictor of response to topiramate in chronic migraine patients
    Astorga, Aldara
    de la Red, Henar
    Gomez-Garcia, Marta
    Ruiz, Marina
    Hernandez, Marta
    Sotelo, Eva
    Guerrero, Angel L.
    CEPHALALGIA, 2017, 37 : 45 - 46
  • [48] Topiramate in migraine prevention
    Silberstein, SD
    HEADACHE, 2005, 45 : S57 - S65
  • [49] Migraine prophylaxis with topiramate
    Gendolla, Astrid
    Diener, Hans Christoph
    PSYCHOPHARMAKOTHERAPIE, 2006, 13 (05): : 184 - +
  • [50] Topiramate in migraine prophylaxis
    D. D’Amico
    L. Grazzi
    S. Usai
    F. Moschiano
    G. Bussone
    Neurological Sciences, 2005, 26 : s130 - s133
12345